How lifelong economic hardship might speed biological aging and affect thinking in midlife
Administrative Supplement: Accelerated Epigenetic Aging as a Mechanism in Lifespan Socioeconomic Effects on Midlife Cognitive Decline
This project looks at whether limited resources across life speed up biological 'epigenetic' aging and lead to worse thinking and memory in adults during midlife.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11411039 on NIH RePORTER |
What this research studies
From my point of view, researchers will combine information about childhood and adult socioeconomic conditions with biological measures of epigenetic aging and repeated thinking tests to see how disadvantage relates to midlife cognition. They will compare four life-course ideas — childhood-sensitive periods, total accumulated exposure, adult pathways, and social mobility — to find when hardship matters most. The work uses existing long-term study data and biological samples to follow changes over time. The team links neighborhood and personal economic history with blood-based epigenetic markers and cognitive change patterns.
Who could benefit from this research
Good fit: Ideal candidates are adults in midlife who can share their childhood and adult socioeconomic history and provide biological samples for epigenetic testing.
Not a fit: People seeking immediate treatments for dementia symptoms or those who cannot provide life-course history or biological samples are unlikely to get direct benefit from this project.
Why it matters
Potential benefit: If successful, this could point to when and how economic hardship speeds biological aging and contributes to earlier cognitive decline, helping target prevention and public-health efforts.
How similar studies have performed: Other studies have linked socioeconomic disadvantage to poorer cognition and linked epigenetic age to aging outcomes, but directly connecting life-course timing of disadvantage to epigenetic aging and midlife cognitive decline is a newer approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Reed, Rebecca G — University of Pittsburgh at Pittsburgh
- Study coordinator: Reed, Rebecca G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.